RedHill Biopharma Ltd (RDHL)

[midastouch017]

RedHill Biopharma to Present at the 9th Annual BioPharm America International Partnering Conference

TEL-AVIV, Israel, Sept. 01, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that Mr. Adi Frish, RedHill’s Senior VP Business Development & Licensing, will be presenting at the 9th Annual BioPharm America International Partnering Conference, on Wednesday, September 14, 2016, at 3:00 pm EDT, at the Boston Marriott Copley Place in Boston, MA.

A copy of the presentation to be made by Mr. Frish is available on the Company's website and may be viewed at: http://ir.redhillbio.com/.